Xiao, Feiyi, Wudong Xiao, Xue Li, Rui Li, and Kun Zhao. “Cost-Effectiveness Analysis of Trastuzumab Deruxtecan As Second-Line Treatment for HER2- Positive Advanced Breast Cancer”. Health Decision 2, no. S1 (July 12, 2024). Accessed May 2, 2025. https://www.hksmp.com/journals/hd/article/view/655.